Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Pathway Type:



Showing 81 - 90 of 605359 pathways
SMPDB ID Pathway Name and Description Pathway Class Chemical Compounds Proteins

SMP0143947

Pw145615 View Pathway

Afamelanotide Drug Metabolism Action Pathway

Drug Action
  • Afamelanotide

SMP0144221

Pw145889 View Pathway

Afatinib Drug Metabolism Action Pathway

Drug Action
  • Afatinib

SMP0144052

Pw145720 View Pathway

Agomelatine Drug Metabolism Action Pathway

Drug Action

SMP0126726

Pw128330 View Pathway

Agomelatine Serotonin Antagonist Action Pathway

Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors and promotes dopamine and norepinephrine release. Agomelatine is indicated to treat major depressive episodes in adults. It is an atypical antidepressant.
Drug Action

SMP0126271

Pw127860 View Pathway

Ajmaline Action Pathway

Ajmaline is an antiarrhythmic used to manage a variety of forms of tachycardias. It can be found under the brand names Gilurytmal, Ritmos, and Aritmina. An alkaloid found in the root of Rauwolfia serpentina, among other plant sources. It is a class Ia antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials. Ajmaline produces potent sodium channel blocking effects and a very short half-life which makes it a very useful drug for acute intravenous treatments. The drug has been very popular in some countries for the treatment of atrial fibrillation in patients with the Wolff–Parkinson–White syndrome and in well tolerated monomorphic ventricular tachycardias. It has also been used for many years as a drug to challenge the conduction system of the heart in cases of bundle branch block and syncope. In these cases, abnormal prolongation of the HV interval has been taken as a proof for infrahisian conduction defects tributary for permanent pacemaker implantation. The class I antiarrhythmic agents interfere with the sodium channel. A class IA agent lengthens the action potential (right shift) which brings about improvement in abnormal heart rhythms. This drug in particular has a high affinity for the Nav 1.5 sodium channel. Some side effects of using ajmaline may include warm flushes, tingling skin, vertigo, and eye twitches.
Drug Action

SMP0143760

Pw145428 View Pathway

Ajmaline Drug Metabolism Action Pathway

Drug Action

SMP0144429

Pw146097 View Pathway

Alatrofloxacin Drug Metabolism Action Pathway

Drug Action
  • Alatrofloxacin

SMP0125847

Pw127418 View Pathway

Albendazole Action Pathway

Albendazole is a broad-spectrum benzimidazole anthelmintic used to treat parenchymal neurocysticercosis and other helminth infections. Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by diminishing its energy production, ultimately leading to immobilization and death of the parasite. It works by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. As cytoplasmic microtubules are critical in promoting glucose uptake in larval and adult stages of the susceptible parasites, the glycogen stores of the parasites are depleted. Cellular glucose dissipates which results in decreased production and dissipation of adenosine triphosphate (ATP), which is the energy required for the survival of the helminth. Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes also result in decreased production of adenosine triphosphate (ATP),
Drug Action

SMP0142969

Pw144637 View Pathway

Albendazole Drug Metabolism Action Pathway

Drug Action

SMP0144107

Pw145775 View Pathway

Alcaftadine Drug Metabolism Action Pathway

Drug Action
Showing 81 - 90 of 4295 pathways